Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Triton on acquisition of Fläkt Woods
Mandate

Vinge advises Triton on acquisition of Fläkt Woods

August 24, 2016 M&A

Vinge advises funds managed by Triton in connection with the acquisition of Fläkt Woods Group. Fläkt Woods Group is a global leader for air technologies on air treatment, air diffusion and air movement. Closing of the transaction is subject to applicable regulatory approvals. The company, with locations in 25 countries in all regions of the world, earns EUR 423 million in sales. It employs more than 2,100 people.

The Vinge team includes Christina Kokko together with Matthias Pannier and Johanna Wiberg (corporate), Johan Cederblad (environmental), Andréa Nicolin (commercial contracts), Anna Lonergan (real estate), Tomas Forsgren (IP), Linn Gustavsson (compliance), Karin Isacson (employment) och Mika Jordan (IT).

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026